Archive for November 2021
Long-COVID and Epstein-Barr Virus reactivation
The prevalence of persistent symptoms after the resolution of acute illness in COVID-19 is approximately 30%. Known as long-COVID, these symptoms include fatigue, brain fog, sleep difficulties, arthralgia, pharyngitis, myalgia, headaches, fever, gastrointestinal upset, and skin rashes with a variety of presentations. Symptoms of long-COVID have also been observed in those with asymptomatic, mild and…
Read MoreWithania and the evidence of it’s neuroprotective effects
Mental health and neurological disorders are significant global public health concerns, affecting more than 100 billion individuals worldwide. Conventional pharmacological treatments of these disorders may offer some symptom relief, but are expensive, have limited efficacy, and are associated with multiple side effects.1 As a result, there has been increased interest in the use of herbal therapies…
Read More